Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other financing activities (2023)

Historic Other financing activities for Ptc Therapeutics (PTCT) over the last 1 years, with Q3 2023 value amounting to $85000.0.

  • Ptc Therapeutics' Other financing activities changed N/A to $85000.0 in Q3 2023 from the same period last year, while for Dec 2023 it was $282000.0, marking a year-over-year change of. This contributed to the annual value of $282000.0 for FY2023, which is 9753.8% down from last year.
  • As of Q3 2023, Ptc Therapeutics' Other financing activities stood at $85000.0.
  • Ptc Therapeutics' 5-year Other financing activities high stood at $182000.0 for Q1 2023, and its period low was $15000.0 during Q2 2023.